Exelixis
Recent News About Exelixis
-
Lamb: 'Expanding our biotherapeutics pipeline is a key strategic priority'
Exelixis, Inc. has entered an option and license agreement with BioInvent International AB to identify and develop novel antibodies for use in IO therapeutics, according to a press release.